Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CORT
HALO
Add up to 3 more stocks
CORT
Corcept Therapeutics Incorporated
-3.27%
$118.04-3.99Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$12.76B
52W Range
$28.66 - $126.38
HALO
Halozyme Therapeutics, Inc.
+0.74%
$109.11+0.80Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$12.94B
52W Range
$61.23 - $116.85
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 281.04 | 32.57 |
| Forward P/E | N/A | 12.97 |
| PEG Ratio | N/A | 1.42 |
| P/B Ratio | 18.08 | 90.16 |
| P/S Ratio | 15.36 | 7.78 |
| P/FCF Ratio | 119.34 | 16.05 |
| EV/EBITDA | 1434.32 | 14.15 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 98.3% | 78.2% |
| Operating Margin | 0.8% | 56.8% |
| Net Margin | 6.6% | 24.9% |
| ROE | 7.8% | 288.1% |
| ROA | 6.2% | 16.1% |
| ROIC | 0.9% | 27.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.86 | 2.71 |
| Quick Ratio | 2.77 | 2.31 |
| Debt/Equity | 0.01 | 14.95 |
| Interest Coverage | N/A | 45.03 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.